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ABSTRACT: Hydrogenases are oxygen-sensitive en-
zymes that catalyze the conversion between protons and
hydrogen. Water-soluble subcomplexes of membrane-
bound [NiFe]-hydrogenases (MBH) have been extensively
studied for applications in hydrogen−oxygen fuel cells as
they are relatively tolerant to oxygen, although even these
catalysts are still inactivated in oxidative conditions. Here,
the full heterotrimeric MBH of Ralstonia eutropha,
including the membrane-integral cytochrome b subunit,
was investigated electrochemically using electrodes
modiﬁed with planar tethered bilayer lipid membranes
(tBLM). Cyclic voltammetry and chronoamperometry
experiments show that MBH, in equilibrium with the
quinone pool in the tBLM, does not anaerobically
inactivate under oxidative redox conditions. In aerobic
environments, the MBH is reversibly inactivated by O2,
but reactivation was found to be fast even under oxidative
redox conditions. This enhanced resistance to inactivation
is ascribed to the oligomeric state of MBH in the lipid
membrane.
Hydrogenases are complex microbial metalloenzymes whichcatalyze the reversible oxidation of H2 to protons at rates
comparable to those normally achieved by Pt.1 They are
widespread in the microbial world where they are used to
dispose of excess reducing power (H2 production) or to produce
energy (H2 oxidation).
2 Their ability to selectively interconvert
H2 to H
+s makes them ideal catalysts for H2/O2 biofuel cells.
When they are used in conjunction with a selective catalyst for O2
reduction, like laccase or bilirubin oxidase, it is no longer
necessary to separate the anode from the cathode with a gas
impermeable membrane as required in Pt-based fuel cells.3
Hydrogenases have thus been intensively studied both as an
inspiration to design inorganic catalysts and as biocatalysts
themselves.4 Based on the metal content of the active site, H+-H2
interconverting hydrogenases have been classiﬁed into [NiFe]-
and [FeFe]-hydrogenases. [FeFe]-hydrogenases have high
turnover frequencies for H2 production, but they are inactivated
by trace amounts of O2.
5 [NiFe]-hydrogenases, by contrast, are
generally less sensitive to O2 inactivation and biased toward H2
oxidation.6
[NiFe]-hydrogenases have been further subdivided into
“standard” (O2-sensitive) and O2-tolerant hydrogenases, and
many studies have focused on the elucidation of the origins of the
O2 tolerance.
7 The membrane-bound hydrogenase (MBH) from
the β-proteobacterium Ralstonia eutropha is one of the best
studied O2-tolerant [NiFe]-hydrogenases.
8 It is an uptake
hydrogenase that links H2 oxidation to quinone reduction and
has an outstanding O2 tolerance, capable of maintaining a high
level of activity in the presence of air supplemented with low H2
concentrations.6b,9 As many other uptake [NiFe]-hydrogenases,
it consists of three subunits, one of which is an integral
membrane protein (Figure 1). The [NiFe] active center is
located in the large subunit (α), and three [FeS] clusters are
aligned in the small subunit (β) forming an electron relay.10 The
third subunit is a diheme cytochrome b562, which anchors the
protein complex to the cytoplasmic membrane and transfers
electrons from H2 oxidation to the respiratory chain via the
quinone pool.11 Both ubiquinone and menaquinone have been
proposed to be the native substrate.8b
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Figure 1. Heterotrimeric MBH is incorporated in the tBLM adsorbed
on a mixed self-assembled monolayer made of EO3-cholesteryl (tether)
and 6-mercaptohexan-1-ol (spacer) on the surface of a gold electrode.
The main reactions catalyzed by the enzyme are shown in red. The
ubiquinone (UQ) added to the tBLM is reduced by the cytchrome b562
to ubiquinol (UQH2) which is reoxidized at the electrode. The oxidative
conversion of the [NiFe] site from the Ni−S state to the inactive Ni−B
state is depicted at the top.
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The O2 tolerance of the MBH and of closely related enzymes
has been attributed to the “special” design of the unusual
proximal [4Fe-3S] cluster, which has the ability to provide two
electrons in a narrow potential range, helping to keep a reducing
environment when theMBH reacts with oxygen.2b,7c,f,10,12 When
O2 reacts at the active site, this cluster ensures the formation of
the so-called Ni−B state (Figure 1), also designated as a “ready
inactive” state, which is rapidly reactivated (in a matter of
seconds) under a H2 atmosphere. In contrast, O2-sensitive
[NiFe]-hydrogenases, which have a conventional [4Fe-4S]
cluster at the proximal site, form in addition to Ni−B the
inactive Ni−A state upon reacting with O2, which usually
requires nonphysiological negative potentials to reactivate.9b,13
In addition to crystallography and spectroscopy, protein ﬁlm
electrochemistry (PFE) has been invaluable in elucidating the
inactivation−reactivation mechanism.4e,7g,14 PFE provides a
direct way for monitoring catalytic turnover by adsorbing the
protein on the surface of an electrode (typically a graphite
electrode) and controlling the enzymatic activity via the
electrode potential. PFE studies have shown that [NiFe]-
hydrogenases are inactivated at high potentials in anaerobic
conditions and that inactivation is faster at lowH2 concentrations
(in the low μM range).5,6a,c,7a,13b The H2 oxidation activity drops
as the potential is raised, and it recovers when the active site is
reduced at low potentials. The inactive state formed at high redox
potentials was determined to be the Ni−B state.6c,13b This
anaerobic inactivation mechanism has also been observed with
nonphysiological oxidants.15 Almost all PFE studies on MBH
have employed the hydrophilic αβ subcomplex.5,6a,b,7g,9a,b,14d
Here, we describe a diﬀerent approach, in which the full
heterotrimeric MBH is immobilized at an electrode interface
using a so-called tethered bilayer lipid membrane (tBLM)
(Figure 1).16 Cytoplasmic membrane extracts from R. eutropha,
containing MBH, are tethered to an electrode surface using
cholesterol-based anchor molecules. The full heterotrimeric
structure is retained as the MBH remains in a native-like
membrane environment. By incorporating ubiquinone in the
tBLM, the native catalytic function of the MBH, namely H2-
ubiquinone oxidoreduction, can be studied, where the redox state
of the quinone pool is controlled by the potential applied to the
electrode (Figure 1). We show that the full heterotrimeric MBH
in a lipid environment does not display anaerobic (oxidative)
inactivation, as the hydrophilic subcomplexes do, and that O2-
inactivated MBH rapidly reactivates under oxidative conditions
even when the quinone pool is fully oxidized.
Experiments examining the inﬂuence of pH and temperature
on enzyme activity were carried out to determine the optimum
conditions for monitoring the catalytic activity (Figure 2). The
optimum pH value for H2 oxidation activity seems to lie in the
range of 7 to 8, unlike the heterodimeric αβ subcomplex for
which an optimum between 4.5 and 6.5 was determined (Figure
2a).5,6a,9a A similar diﬀerence in pH optimum was reported in a
study employing spectrophotometric assays.17 However, we note
that at lower pH, the oxidation wave shifts to higher potentials,
preventing us to reach potentials at which MBH is fully active as
the tBLM system is damaged by potentials higher than 0.6 V. The
shift in potential is a consequence of the pH dependence of the
ubiquinol oxidation potential. We also propose that the absence
of clear current plateaus at high potential (Figure 2) is due to the
particular kinetic properties of the electrochemical oxidation of
ubiquinol, which is coupled or “gated” by slow proton release in
the lipid bilayer.18 Above pH 8 the enzymatic activity sharply
drops, and no recovery is observed when the pH is subsequently
lowered, suggesting denaturation of MBH at high pH. TheMBH
in the tBLM is stable at temperatures up to 50 °C, although some
loss of activity is observed on time-scales in the order of hours at
temperatures above 30 °C (Figure 2b). Consequently all the
following experiments were performed at 30 °C and pH 7.4.
Control experiments were carried out by recording cyclic
voltammograms (CVs) of tBLMs prepared from cytoplasmic
membranes lacking the αβ subcomplex of the MBH, which
showed no H2 oxidation activity.
CVs recorded under 100% N2 (Figure 2, gray lines) show no
catalytic oxidation waves, instead uncovering the oxidation and
reduction signals of the ubiquinone pool in the tBLM. The large
peak separation of the ubiquinone electrochemistry has
previously been studied in detail and is caused by the coupling
of the electron transfer with protonation/deprotonation steps,
which are slow due to the lipid bilayer environment.18 The onset
of H2 oxidation (black line) coincides with ubiquinol oxidation
(Figure 2c), conﬁrming the fact that the electron transfer
between the MBH and the electrode takes place via the quinone
pool. A clear feature in all the catalytic oxidation waves in Figure
2 is the absence of any anaerobic inactivation at high potential.
Previous studies have shown that the anaerobic inactivation of
the heterodimeric αβ subcomplex of MBH is more pronounced
at low substrate concentrations and slow scan rates.6a,14d
Therefore, CVs were recorded at 1 mV/s under 0.5% (4.0
μM) and 0.1% (0.8 μM) H2 (insert in Figure 2c and Figure S1).
In either condition, no decrease in current is observed as the
potential is swept toward positive values, which conﬁrms that the
heterotrimeric MBH in equilibrium with the quinone pool
displays little or no anaerobic inactivation even in substrate
limiting conditions.
Figure 2.CVs showing the inﬂuence of (a) pH, (b) temperature, or (c, d) quinone pool on enzyme activity in anaerobic conditions. H2 concentrations as
indicated. All experiments were performed at 10 mV/s, pH 7.4, 30 °C unless stated otherwise. Inset of (c) was measured at 1 mV/s. The arrows in (c)
indicate the direction of scan. The CVs in (b) were measured with less MBH in the tBLM compared to (a, c, and d) (see the Experimental Section in SI).
(a−c) were measured using 1% (w/w) ubiquinone-10 to lipid ratio in the membrane and (d) was measured with 2% (w/w) menaquinone-7.
Abbreviations: SHE, standard hydrogen electrode; Re, Ralstonia eutropha.
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To conﬁrm that also menaquinone can act as electron acceptor
of MBH, as previously proposed,8b experiments were performed
with added menaquinone (Figure 2d, see SI for details).
Menaquinone is oxidized at a lower potential than ubiquinone,
and consequently the onset of hydrogen oxidation is visible from
about−0.1 V onward, about 0.3 V lower. The reduction potential
of menaquinone is only∼0.2 V lower than ubiquinone. However,
as already mentioned, the quinone oxidation in tBLMs is coupled
to the deprotonation of the quinol.18 Apparently, diﬀerences
between deprotonation rates and/or pKas between menaqui-
none and ubiquinone cause an additional 0.1 V shift.
In Figure 2d, a slight shoulder around 0.3 V is visible, which is
due to trace amounts of ubiquinone-8 present in the tBLM. This
ubiquinone originates from the Escherichia coli lipid extract as
well as the cytoplasmic membrane extracts from R. eutropha that
were used to prepare the tBLM (see SI for details). Similar to the
experiments with ubiquinone, no inactivation is observed at high
potentials.
Using a method developed by Leǵer et al.,19 the apparent
Michaelis−Menten constant for hydrogen (KM(app)) was
calculated with ubiquinone as electron acceptor. The method
involves the addition of a H2-saturated aliquot to a stirred
working solution which is continuously ﬂushed with N2, while
the working electrode potential is maintained at a ﬁxed positive
value (Figure 3a). The value of KM(app) can be calculated by
analyzing the sigmoidal current decay as the gases (in this case
H2) are removed from solution following an exponential decay.
The exponential time-dependency of gas removal from solution
was conﬁrmed through independent experiments (see Figure
S2). Table 1 shows that KM(app) increases with the applied
electrode potential, suggesting that at high H2 concentrations
ubiquinol/ubiquinone cycling might be limiting the rate of H2
oxidation, especially at potentials below 0.5 V. CVs were
measured at increasing H2 concentration to further support the
KM(app) values in Table 1 (see Figure S3). As previously reported
with PFE, a delay is observed in Figure 3a between the time of H2
injection and the time at which the maximum activity is attained
(∼50s).9a The origin of this delay remains unclear, and studies
are ongoing to test if this delay is due to reactivation ofMBH that
has been inactivated in the absence of hydrogen.
Aerobic inactivation was investigated using chronoamperom-
etry by adding an aliquot of air-equilibrated buﬀer to the stirred
working solution while the current resulting fromH2 oxidation is
monitored in time (Figure 3b). The electrode potential is held at
a constant positive value at which the ubiquinone remains almost
fully oxidized, ensuring a suﬃciently high H2 oxidation activity of
theMBH.We note that ubiquinol oxidases are also present in the
cytoplasmic membrane extracts and will oxidize ubiquinol in the
presence of O2. This will reduce the observed catalytic current
due to H2 oxidation. The catalytic activity of ubiquinol oxidases
can be directly observed at low potentials in CVs recorded in the
presence of 10% O2 (Figure S4). After addition of 57 μM O2
(equivalent to one-fourth of the ambient concentration of
dissolved O2), the H2 oxidation current drops very fast to ∼75 ±
1.4% (n = 12) of the initial current due to the oxidative
conversion of the [NiFe] active site to the Ni−B state and
possibly due to competing oxygen reduction (Figure 3b). The
same behavior was observed at the higher potentials of 0.5 V. In
the presence of 5% O2 (50 μM), MBH thus maintains at least
three-quarters of its initial activity and begins to recover activity
immediately after the injection, long before all O2 is ﬂushed out
of the cell by H2. The observed recovery in current seems to
mirror that of the predicted O2 concentration in the cell,
suggesting that activation and inactivation kinetics of MBH are in
equilibrium during the experiment or that the decrease in current
is solely due to ubiquinol oxidase activity. Importantly, the
recovery of activity does not require less oxidative potentials,
indicating that the “ready” inactive state (Ni−B) can be reduced
back to the active state even when the ubiquinone pool is almost
fully oxidized.
In conclusion, the present study shows that, unlike the
hydrophilic heterodimeric subcomplex, the heterotrimericMBH,
in equilibrium with the quinone pool, does not undergo
anaerobic inactivation under oxidative redox conditions. This
implies that when the cytochrome b562 subunit is in equilibrium
with its substrate (the ubiquinone pool) and acts as a primary
electron acceptor of the hydrophilic αβ heterodimer, the [NiFe]
active site is protected from permanently resting in the Ni−B
state, even when H2 is scarce and the ubiquinone pool almost
fully oxidized. In addition, although MBH is inactivated by O2 it
immediately recovers activity even under highly oxidative redox
conditions. We cannot exclude the possibility that reactivation
(reduction of the Ni−B state) is driven by ubiquinol oxidation by
a reversed electron ﬂow from cytochrome b562 to the [NiFe]
active site. However, at the extreme potentials applied (up to 0.6
V), we expect that only diminishing amounts of reduced
ubiquinol are present in the tBLM. Instead, we propose that
reactivation is related to the occurrence of higher oligomeric
states of the MBH in the membrane. We have previously
provided evidence to indicate that MBH forms tripartite
supercomplexes of heterotrimeric complexes in the native lipid
membrane and proposed that one heterotrimer donates
electrons from H2 oxidation to reactivate a neighboring
heterotrimer which is in the Ni−B state.8b Recently, a crystal
structure of a dimer of a MBH subcomplex from E. coli
(hydrogenase 1) showed that the distance between two distal
Figure 3. (a) Chronoamperogram showing the evolution of the MBH
activity after the injection of a H2-saturated aliquot of buﬀer into the cell
solution ﬂushed with N2 (+0.497 V vs SHE; 30 °C, pH 7.4). (b)
Chronoamperometry of the MBH (+0.397 V vs SHE, 100% H2, pH 7.4,
30 °C). The current is used to determine the hydrogen oxidation
activity, which is normalized to 100% at the start of the experiment. An
aliquot (one-fourth volume of the ﬁnal cell volume) of air-saturated
buﬀer was inserted into the electrochemical cell at 270 s. The
exponential decay of the O2 concentration was plotted according to
the equation:C(t) =C(0) exp(−t/τ),C is concentration, t is time), and τ
is the time constant for exponential gas removal and was determined to
be 22 s under these conditions (see Figure S2).
Table 1. Value of KM(app) (± SEM) at Diﬀerent Potentials
a
potential (V vs
SHE) +0.397 +0.497 +0.597
KM(app) (μM) 1.5 ± 0.3 (n = 3) 2.1 ± 0.9 (n = 8) 9.2 ± 2.7 (n = 5)
aNumber of independent experiments is given by n.
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[FeS] clusters is short, supporting the hypothesis that
intermolecular electron transfer is possible.20
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